# OnCo record idea-caix-theranostics (idea). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/ideas/idea-caix-theranostics/>
  a schema:CreativeWork ;
  onco:kind "idea" ;
  schema:identifier "idea-caix-theranostics" ;
  schema:name "CAIX theranostics: 89Zr-girentuximab PET and 177Lu/225Ac-girentuximab therapy"@en ;
  schema:description "Almost every clear-cell kidney cancer carries the CAIX protein. Image it with one radioactive antibody, then treat with the same antibody carrying a therapeutic isotope."@en ;
  schema:url <https://onco.cc/ideas/idea-caix-theranostics/> ;
  schema:dateModified "2026-09-07"^^xsd:date ;
  schema:citation <https://doi.org/10.1016/S1470-2045(24)00402-9> ;
  onco:cancers <https://onco.cc/cancers/rcc/> ;
  onco:technologies <https://onco.cc/technologies/caix-pet/>, <https://onco.cc/technologies/radioligand-therapy/>, <https://onco.cc/technologies/targeted-alpha-therapy/>, <https://onco.cc/technologies/radioimmunotherapy/> ;
  onco:targets <https://onco.cc/targets/hif2a/> ;
  onco:companies <https://onco.cc/companies/telix/> ;
  onco:keyPapers <https://onco.cc/key-papers/paper-shuch-lancet-oncol/> .